Search results
New research platform assesses brain cancer mutations during surgery
Medical Xpress· 5 days agoBrain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year survival rate ...
Researchers create 'chameleon' compound that targets drug-resistant brain cancers
Medical Xpress· 1 day agoThe research, published in the Journal of the American Chemical Society, is a crucial step in the development of so-called "chameleon compounds" that may be used to target an array of pernicious ...
Walk six laps for Emerson the Brave, a 12-year-old battling cancer in Holland
The Holland Sentinel· 1 day ago— A walkathon next week will raise funds for a local child battling brain cancer. West Ottawa Public...
Community supports 12-year-old cancer patient who ‘beat the unbeatable’
WOOD via Yahoo News· 21 hours agoEmerson Hoogendoorn's loved ones say she can be described in many words: kind, strong, giving. But...
Agios (AGIO) Up 23% on Selling Brain Cancer Drug Royalty
Zacks via Yahoo Finance· 6 days agoAgios Pharmaceuticals (AGIO) agrees to sell to Royalty Pharma the rights to royalties on potential...
Epsom Derby: Mother backs event to honour daughter
BBC News· 5 days agoA mother from Surrey is marking the fifth anniversary of her daughter’s death by supporting a charity hat auction at the Epsom Derby. Debi Oliver, a...
Gene therapy offers huge potential for combating disease, doctors say
United Press International via Yahoo News· 4 days agoResearchers are engineering ways to alter genes or swap flawed ones with healthy replacements,...
Why Are Younger People Getting Cancer?
US News Health· 6 days agoAt age 20, while studying sports management and marketing in college, Sean Kukoleck's life was disrupted by cancer. Cancer screenings are happening at younger ...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 3 days agoResults from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging anti-tumor activity and duration of treatment Initial data from Phase 0/1 “trigger” (“window of
